Todd M W, Keith T D, Foster M T
Am J Hosp Pharm. 1987 Mar;44(3):529-35.
A comprehensive drug-use review (DUR) program based on established criteria for use of each drug is described. The DUR program was developed to promote cost-effective drug therapy and satisfy Joint Commission on Accreditation of Hospitals standards for drug-use evaluation. Antibiotic and ambulatory-care drug-use subcommittees composed of physicians, pharmacists, nurses, and clinical laboratory personnel were formed as advisory groups to the pharmacy and therapeutics (P&T) committee. The subcommittees review overall drug-use patterns in their respective areas monthly and investigate the use of specific problem drugs. Drug-use reviews have been facilitated by the implementation of a mandatory antibiotic order form and pharmacy computer systems. Nonformulary drug use is monitored. The procedure for adding drugs to the formulary was modified to require the submission of specific criteria for appropriate drug use; when a drug is added to the formulary, the criteria for use are also adopted. The program has been successful in curtailing inappropriate drug use, reducing drug expenditures, and integrating P&T committee decisions into daily pharmacy practice. The implementation of this DUR program has enabled the P&T committee to conduct ongoing, systematic, criteria-based drug-use evaluations.
本文描述了一个基于每种药物既定使用标准的综合药物使用审查(DUR)项目。该DUR项目旨在促进具有成本效益的药物治疗,并满足医院评审联合委员会关于药物使用评估的标准。由医生、药剂师、护士和临床实验室人员组成的抗生素和门诊护理药物使用小组委员会作为药学与治疗学(P&T)委员会的咨询小组成立。这些小组委员会每月审查各自领域的总体药物使用模式,并调查特定问题药物的使用情况。通过实施强制性抗生素订单表和药房计算机系统,促进了药物使用审查。非处方药物的使用受到监测。将药物添加到处方集的程序进行了修改,要求提交适当药物使用的具体标准;当一种药物被添加到处方集时,使用标准也会被采用。该项目在减少不适当的药物使用、降低药物支出以及将P&T委员会的决策纳入日常药房实践方面取得了成功。这个DUR项目的实施使P&T委员会能够进行持续、系统、基于标准的药物使用评估。